Neos Therapeutics, Inc. Business Finance Contracts & Agreements

Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,... (Filed With SEC on March 22, 2021)

Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Filed With SEC on March 22, 2021)

Subordination Agreement, by and among Neos, Aytu, Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos Therapeutics Commercial, LLC, Pharmafab Texas, LLC and Encina Business... (Filed With SEC on February 8, 2021)

Subordination Agreement, by and among Neos, Aytu, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P (Filed With SEC on February 8, 2021)

Registration Rights Agreement, by and between Neos and Aytu (Filed With SEC on February 8, 2021)

Unsecured Convertible Promissory Note, by and between Neos and Aytu (Filed With SEC on February 8, 2021)

Limited Waiver to Loan and Security Agreement, dated as of December 10, 2020, by and between Neos, Encina and Encina Business Credit SPV, LLC (Filed With SEC on December 11, 2020)

Commitment Letter, dated as of December 10, 2020, by and between Encina, Encina Business Credit SPV, LLC, Neos and Aytu (Filed With SEC on December 11, 2020)

Limited Waiver, dated as of December 10, 2020, by and between Neos and the Deerfield Lenders (Filed With SEC on December 11, 2020)

Form of Unsecured Convertible Promissory Note, by and between Neos and Aytu (Filed With SEC on December 11, 2020)

Limited Waiver, dated as of November 9, 2020, among the Registrant, its subsidiary guarantors, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P., as lenders,... (Filed With SEC on November 9, 2020)

U.S. Small Business Administration Paycheck Protection Program Note dated April 18, 2020 by and between the Registrant and First Republic Bank (Filed With SEC on May 11, 2020)

Fifth Amendment to Facility Agreement, dated as of May 6, 2020, by and among Neos Therapeutics, Inc., the guarantor parties thereto, Deerfield Private Design Fund III, L.P. and... (Filed With SEC on May 7, 2020)

Form of Second Amended and Restated Senior Secured Convertible Note (Filed With SEC on May 7, 2020)

Description of Capital Stock (Filed With SEC on March 13, 2020)

Fourth Amendment to the Facility Agreement, dated as of October 2, 2019, by and between Deerfield Private Design Fund III, L.P., Deerfield Special Situations Fund, L.P. and... (Filed With SEC on October 3, 2019)

Loan and Security Agreement, dated as of October 2, 2019, by and between Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC and Neos Therapeutics, LP, as borrowers, Neos... (Filed With SEC on October 3, 2019)

Third Amendment to Facility Agreement dated as of March 26, 2019 by and among the Registrant, Deerfield Private Design Fund III, L.P., and Deerfield Special Situations Fund, L.P (Filed With SEC on May 10, 2019)

Underwriting Agreement, dated November 6, 2018, between Neos Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 6, 2018)

Form of Senior Secured Convertible Promissory Note (Filed With SEC on November 5, 2018)

Second Amendment to Facility Agreement, dated as of November 5, 2018, by and among Neos Therapeutics, Inc., Deerfield Private Design Fund III, L.P. and Deerfield Special Situation... (Filed With SEC on November 5, 2018)

Registration Rights Agreement, dated as of November 5, 2018, by and among Neos Therapeutics, Inc., Deerfield Private Design Fund III, L.P. and Deerfield Special Situation Fund, L.P (Filed With SEC on November 5, 2018)

NEOS THERAPEUTICS, INC. 4,800,000 Shares of Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT June 26, 2017 (Filed With SEC on June 29, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 5, 2017)

FIRST AMENDMENT TO FACILITY AGREEMENT (Filed With SEC on June 5, 2017)

SENIOR SECURED CONVERTIBLE NOTE (Filed With SEC on June 5, 2017)

NEOS THERAPEUTICS, INC. 5,000,000 Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on February 3, 2017)

FACILITY AGREEMENT (Filed With SEC on August 12, 2016)

NEOS THERAPEUTICS, INC. AMENDMENT AND WAIVER (Filed With SEC on March 18, 2016)

NEOS THERAPEUTICS, INC. [ ] Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on July 13, 2015)

NEOS THERAPEUTICS, INC. 2009 EQUITY PLAN EMPLOYEE NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. THIRD AMENDED AND RESTATED SUBORDINATED PROMISSORY NOTE (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT June 9, 2015 (Filed With SEC on June 19, 2015)

WARRANT AGREEMENT NEOS THERAPEUTICS, INC. (Filed With SEC on June 19, 2015)

NEOS THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on June 19, 2015)